Cytek Biosciences, Inc. (CTKB) vs InMode Ltd. (INMD)
A side-by-side comparison of Cytek Biosciences, Inc. and InMode Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTKB
Cytek Biosciences, Inc.
$5.98HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
INMD
InMode Ltd.
$14.11HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
Total return — CTKB vs INMD
growth of $100 · dividends reinvested · last 5yCTKB -67.5% (-20.1%/yr)INMD -74.2% (-23.8%/yr)CTKB compounded faster over this window
CTKB INMD
CTKB vs INMD: by the numbers
- •INMD is the larger company ($811M vs $772M market cap).
- •INMD is profitable (20.69% net margin) while CTKB runs a net loss (-38.98%).
- •CTKB grew revenue faster over the past five years (13.37% vs 5.42% CAGR).
Metrics side by side
Valuation
| Metric | CTKB | INMD |
|---|---|---|
| P/E ratio | N/A | 11.47 |
| Forward P/E | N/A | 10.89 |
| PEG ratio | N/A | 1.15 |
| P/S ratio | 3.74 | 2.16 |
| P/B ratio | 2.40 | 1.29 |
| EV / EBITDA | N/A | 6.00 |
| FCF yield | N/A | 10.78% |
Profitability
| Metric | CTKB | INMD |
|---|---|---|
| Gross margin | 53.23% | 76.52% |
| Operating margin | -21.60% | 18.47% |
| Net margin | -38.98% | 20.69% |
| ROE | -25.03% | 12.32% |
| ROIC | -12.00% | 9.20% |
Growth (annualized)
| Metric | CTKB | INMD |
|---|---|---|
| Revenue CAGR (5Y) | 13.37% | 5.42% |
| EPS CAGR (5Y) | N/A | 6.87% |
| FCF CAGR (5Y) | N/A | 1.36% |
| Total return CAGR (5Y) | -23.16% | -27.48% |
Frequently asked
- Which has grown faster, CTKB or INMD?
- Over the past five years, CTKB grew revenue faster — CTKB at a 13.37% CAGR versus INMD at 5.42%.
- Is CTKB or INMD more profitable?
- INMD runs the higher net margin — CTKB at -38.98% versus INMD at 20.69%.
- How have CTKB and INMD total returns compared?
- Over the past 5 years, CTKB delivered -23.16% and INMD delivered -27.48% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
InMode P/E ratioCytek Biosciences ROEInMode ROECytek Biosciences operating marginInMode operating marginCytek Biosciences revenue growthInMode revenue growthCytek Biosciences free cash flowInMode free cash flow
Cytek Biosciences & InMode appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.